Vikas Goyal
Partner, Growth Investments Longwood Funds
Vikas Goyal is a Partner focused on Growth Investments at Longwood Fund, where he invests in late preclinical and clinical-stage biotechnology companies and supports company-building and strategic development. He brings over 20 years of experience across venture investing and biopharma business development, previously serving as Managing Partner at Trekk Venture Partners and Senior Vice President of Business Development at Pandion Therapeutics, which was acquired by Merck. Earlier in his career, he invested in and supported multiple biotech companies at SR One and began his career in pharmaceutical consulting at McKinsey & Company. He holds an MBA from the Wharton School and a BA in Neurobiology from Harvard University.
Seminars
- How are each of the modality landscapes discussed facilitating successful VC exits and what does that mean for the future of investment in these areas?
- How have changes to the barrier to entry for new innovations fed through into investment?
- What will drive or inhibit future investment in these target modalities?
- How to progress discussions with investors. What is expected and helpful to understand from biotech, from the investor perspective?
- Starting with a short investor panel introducing investor interests and moving into an organised networking session.
- Mirroring the Pharma Introduction Tables, select the investors that best align with your organisation’s stage and objectives, and join their networking table for 30-minutes. Share business cards or ask a follow-up question from the panel with your target investor to tick off another key connection at the conference.
